ReviewMarine drugs2016
Extracellular Metabolites from Industrial Microalgae and Their Biotechnological Potential.
Review in Marine drugs, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed.
- Microalgae-based aquafeeds for penaeid shrimp: progress toward improved growth, immune modulation, and sustainable production.Veterinary research communications · 2026Review
- Extracellular Enzyme Activity and Growth of Chlorella sorokiniana in Response to COCurrent microbiology · 2026Article
- Role of exopolysaccharide secreted by Chlorella vulgaris SSAU 8 and Desertifilum salkalinema SSAU 7 in fertility enhancement of saline soil.Folia microbiologica · 2025Article
- Novel biostimulant bacterial exopolysaccharides production via solid-state fermentation as a valorisation strategy for agri-food waste.Environmental science and pollution research international · 2025Article
- Development and Perfection of Marine-Based Insecticide Biofilm for Pea Seed Protection: Experimental and Computational Approaches.Molecules (Basel, Switzerland) · 2025Article
- Foliar Application of Chlorella Supernatant Protects Turfgrass against Clarireedia jacksonii by Eliciting Induced Resistance and Modulating the Rhizosphere Microbiota.The plant pathology journal · 2025Article
- Shotgun metagenomics reveals the flexibility and diversity of Arctic marine microbiomes.ISME communications · 2025Article
- Antimicrobial properties of selected microalgae exopolysaccharide-enriched extracts: influence of antimicrobial assays and targeted microorganisms.Frontiers in microbiology · 2025Article
- A sulfated exopolysaccharide derived from Chlorella sp. exhibiting in vitro anti-α-D-Glucosidase activity.Archives of microbiology · 2024Article
- Isolation and characterization of cyanobacteria and microalgae from a sulfuric pond: Plant growth-promoting and soil bioconsolidation activities.AIMS microbiology · 2024Article
- High Arctic seawater and coastal soil microbiome co-occurrence and composition structure and their potential hydrocarbon biodegradation.ISME communications · 2024Article
- Diatom-Bacteria Interactions in the Marine Environment: Complexity, Heterogeneity, and Potential for Biotechnological Applications.Microorganisms · 2023Review
- Coral endosymbiont growth is enhanced by metabolic interactions with bacteria.Nature communications · 2023Article
- Characterization of Silver Nanoparticle Systems from Microalgae Acclimated to Different COACS omega · 2023Article
- The Potential of Allelochemicals from Microalgae for Biopesticides.Plants (Basel, Switzerland) · 2023Review
- Saturated and Polyunsaturated Fatty Acids Production byMarine drugs · 2023Article
- Recent advances in modified poly (lactic acid) as tissue engineering materials.Journal of biological engineering · 2023Review
- Extracellular Polymeric Substances Drive Symbiotic Interactions in Bacterial‒Microalgal Consortia.Microbial ecology · 2022Article
- Pb(II)-phycoremediation mechanism usingHeliyon · 2022Article
- Synergistic integration of wastewaters from second generation ethanol plant for algal biofuel production: an industrially relevant option.3 Biotech · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Industrial microalgae, as a big family of promising producers of renewable biomass feedstock, have been commercially exploited for functional food, living feed and feed additives, high-value chemicals in nutraceuticals, cosmeceuticals, and chemical reagents. Recently, microalgae have also been considered as a group that might play an important role in biofuel development and environmental protection. Almost all current products of industrial microalgae are derived from their biomass; however, large amounts of spent cell-free media are available from mass cultivation that is mostly unexploited. In this contribution we discuss that these media, which may contain a remarkable diversity of bioactive substances are worthy to be recovered for further use. Obviously, the extracellular metabolites from industrial microalgae have long been neglected in the development of production methods for valuable metabolites. With the advances in the last ten years, more and more structures and properties from extracellular metabolites have been identified, and the potential utilization over wide fields is attracting attention. Some of these extracellular metabolites can be potentially used as drugs, antioxidants, growth regulators or metal chelators. The purpose of this review is to provide an overview of the known extracellular metabolites from industrial microalgae which might be of commercial interest. The attention mainly focuses on the reports of extracellular bioactive metabolites and their potential application in biotechnology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.